Parveen Shiraz

20PUBLICATIONS
86CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)HaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Transplantation immunologyMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Apr 04, 2026
Dynamics of BCMA expression in patients with relapsed/refractory multiple myeloma receiving BCMA-directed CAR-T therapy.

Masooma Shifa Rana, Sebastian Fernandez-Pol, Alexandria Jensen

|Mar 05, 2026
Nonmyeloablative conditioning combined with the anti-CD117 antibody briquilimab in older adults with high-risk AML and MDS.

Lori S Muffly, Catherine J Lee, Arpita Gandhi

|Jan 06, 2026
Axicabtagene ciloleucel in combination with rituximab for refractory large B cell lymphoma: the phase 2, single-arm ZUMA-14 trial.

Paolo Strati, Lori Leslie, Parveen Shiraz

|Nov 24, 2025
CAR19 therapy drives expansion of clonal hematopoiesis and associated cytopenias.

Mark P Hamilton, Nick Phillips, Troy Noordenbos

|Jan 10, 2025
Donor regulatory T-cell therapy to prevent graft-versus-host disease.

Everett H Meyer, Anna Pavlova, Alejandro Villar-Prados

|Jul 05, 2024
A phase 1 clinical trial of NKTR-255 with CD19-22 CAR T-cell therapy for refractory B-cell acute lymphoblastic leukemia.

Hrishikesh Srinagesh, Clayton Jackson, Parveen Shiraz

Pageof 4

Frequent Collaborators

16 joint publications

Lori S Muffly

11 joint publications

Surbhi Sidana

10 joint publications

Sally Arai

10 joint publications

David Miklos